← All earnings call summaries
Shaily Engineering Plastics Limited — Q1FY27 Earnings Call Summary
Key Takeaways
- Industrial segment revenue up 25% to 23cr; new projects in Consumer Electronics and Automotive
- Capex: 5cr for Semiconductor Trays; 80-100cr for new Consumer Electronics plant
- Q1 FY27 revenue 281cr +14% y-y; EBITDA 83cr +18%, margin 29.7% +120bps; PAT 48cr +17%, margin 17.1% +40bps
- New lines ramp-up ongoing; expect efficiency improvements and potential to exceed 36 million pens guidance
- Consumer segment revenue declined 24% to 116cr due to softer demand in Europe and US
- Pen injector capacity to reach 75 million pens p.a. by Sept; 9 million pens done in Q1, 50-60% GLP-1
- Emergency use, reusable, and on-body auto-injectors in development; reusable to launch by year-end
- Healthcare revenue grew 85% to 142cr, largest segment; driven by pen injectors including GLP-1 and insulin
- Domestic revenue share rising due to Healthcare and new segments; exports still majority
- Management confident on scaling Healthcare business and expanding strategic partnerships in US and Europe
📄 Source: View original transcript (PDF)
Get Shaily Engineering Plastics Limited earnings summaries on Telegram
Add Shaily Engineering Plastics Limited to your watchlist. Receive AI-generated summaries within hours of every earnings call.
Start free →
Summary generated by AI from the official transcript filed on BSE/NSE. Not investment advice.